Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00309) | |||||
---|---|---|---|---|---|
Name |
Guanidine
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
guanidine; Iminourea; Aminomethanamidine; Carbamidine; Carbamamidine; 113-00-8; Guanidin; Imidourea; Aminoformamidine; UNII-JU58VJ6Y3B; Guanidine, free base; CHEBI:42820; JU58VJ6Y3B; H2N-C(=NH)-NH2; Guanidine, Hydrochloride; EINECS 204-021-8; BRN 0506044; guanidine group; HSDB 7603; Guandine thiocyanate; CHEMBL821; Epitope ID:140101; NCIOpen2_007946; 4-03-00-00148 (Beilstein Handbook Reference); (NH2)2C=NH; GTPL4783; DTXSID0023117; [N]C(N)=N; BCP26146; ZINC8101126; BDBM50420178; STL223269; AKOS009031425; DB00536; MCULE-1152750770; SBI-0207070.P001; FT-0626820; C17349; AB00053583_04; 113G008; Q183309; A9B89FF5-2922-47CC-82CE-AC4157B624AE; Ribavirin Impurity T; Iminourea;Diaminomethanimine;Guanidinebase;Carbamidine; 90332-86-8
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Lambert-eaton syndrome | ICD-11: 8C62 | [1] | ||
PubChem CID | |||||
Formula |
CH5N3
|
||||
Canonical SMILES |
C(=N)(N)N
|
||||
InChI |
1S/CH5N3/c2-1(3)4/h(H5,2,3,4)
|
||||
InChIKey |
ZRALSGWEFCBTJO-UHFFFAOYSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=3520"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 59.07 | Topological Polar Surface Area | 75.9 | |
XlogP | -1.3 | Complexity | 26.3 | ||
Heavy Atom Count | 4 | Rotatable Bond Count | 0 | ||
Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 1 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Guanidine 125 mg tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Mannitol; Silicon dioxide; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Merck Sharp & Dohme | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.